Skip to main content

News Archive

News Archive - School of Medicine

Tissue-Specific Immunity May Be the Future, if We Can First Learn its Rules

December 28, 2022

UC San Diego study reveals critical insights into the complex biology of tissue-specific T cells, paving the way for a new branch of precision therapeutics in immunity, autoimmunity, and cancer.

Looking for an Early Sign of LATE

December 15, 2022

Researchers at UC San Diego provide new insights into the pathology of limbic predominate age-related TDP-43 encephalopathy, which mimics Alzheimer’s, making it very difficult to identify in living patients.

New Student Program to Help Address Diversity Gap in Health Care Industry

December 14, 2022

UC San Diego Health is the only institution in the region to receive grant funding from the California Department of Health Care Access and Information to provide support for underrepresented high school students interested in entering health care.

UC San Diego Health Named Center of Excellence for Polycystic Kidney Disease

December 13, 2022

UC San Diego Health has been named a Center of Excellence for polycystic kidney disease (PKD) by the PKD Foundation – the leading advocacy group dedicated to finding treatments and a cure for PKD. UC San Diego Health is one of just 28 institutions nationwide to receive this designation.

New Look at an Ancient Disease: Study Finds Novel Treatment Targets for Gout

December 13, 2022

UC San Diego scientists identify a new molecular model and potential therapeutic target for gout, the most common form of inflammatory arthritis.

UC San Diego Health Recognized for Health Equity in Care of Sickle Cell Crisis

December 12, 2022

UC San Diego Health has been awarded the prestigious 2022 California Association of Public Hospitals and Health Systems Quality Leaders Award in the category of health equity.

CRISPR Technology Improves Huntington’s Disease Symptoms in Models

December 12, 2022

Using models, researchers at UC San Diego School of Medicine, with colleagues elsewhere, describe using RNA-targeting CRISPR/Cas13d technology to develop a new therapeutic strategy that specifically eliminates toxic RNA that causes Huntington’s Disease.

Scientists Receive $4.8M to Pursue Gene Therapy for ‘Incurable’ Disease

December 1, 2022

The California Institute for Regenerative Medicine has awarded UC San Diego researchers $4.8 million to advance a gene therapy to treat Friedreich’s ataxia, a rare but devastating neuromuscular disorder.

Urologists Investigate Climate Change, Health Rights and Gender Equity

November 29, 2022

The Urology for Social Responsibility seminar will be offered in the T. Denny Sanford Center Medical Education and Telemedicine on the UC San Diego campus from January 14 to 15, 2023.

Enzyme Drives Cognitive Decline in Mice, Provides New Target for Alzheimer’s

November 28, 2022

UC San Diego researchers identify the PKCα enzyme as a promising therapeutic target in Alzheimer’s disease; a mutation that increases its activity led to biochemical, cellular and cognitive impairments in mice.
Category navigation with Social links